DUBLIN--(BUSINESS WIRE)--The "Coronary Artery Bypass Grafting (CABG) Devices Sector, Global, 2024-2029" report has been added to ResearchAndMarkets.com's offering. This study provides a detailed ...
DURHAM, N.C., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...
For high-risk patients, the method could offer a safer alternative to open-heart surgery.
For women with severe CAD, percutaneous coronary intervention is associated with increased risk for MACCE and all-cause mortality compared with CABG.
The world’s first minimally invasive heart bypass procedure — done without cutting open the chest wall — has been performed ...
Complement activation via C3 and C5 plays an important role in inflammation, vasoconstriction, vascular leakage, leukocyte activation, cardiac damage, and apoptosis. The inhibition of complement ...
Compared with ticagrelor or aspirin alone, 12 months of dual antiplatelet therapy (DAPT) after coronary artery bypass graft surgery is associated with a reduced risk of MACE that persists out to 5 ...
Sponsoring Organizations: the American College of Cardiology and the American Heart Association (developed with the American Association for Thoracic Surgery and the Society of Thoracic Surgeons) ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback